The company said it ran two separate studies, one with cosmetics contract manufacturer Fiablia, the other for Cornwell University to investigate the viability of HNT technology for blood separation.
NaturalNano acting CEO James Wemett said that the feasibility studies carried out for both the Cornwell University and Fiabila were positive, and will lead to commercialization of specific products
The company said that this outcome is likely to lead to the commercialization of an increasing number of products that incorporate the technology in a number of areas, but says that cosmetics is likely to be a particular focus.
Feasibility of HNT in nail varnish
The work NaturalNano and Fiabila undertook together was to investigate the feasibility of using the HNT technology for a new line of nail polished that will be introduced in the spring of 2010.
Based in Paris, France, Fiabila specializes in the development and manufacturing of nail polishes and nail varnish removers that are marketed on a global basis.
The company says it has worked closely with Fiabila’s president Pierre Miansnik, to develop the application for the technology, which has resulted in a contract to supply Fiabila for the next three years.
Incorporating the HNT technology, which the company stresses is naturally occurring, non toxic and environmentally friendly, into nail polish will enhance their durability and general performance, according to the company.
Natural factor gets the vote
Indeed, Miansnik said that crucial to the decision to incorporate the technology into its latest line of nail varnish was the fact that it enabled the company to maintain its commitment to natural-based ingredients in its formulation.
“We are aggressively looking for an acquisition that brings our technology forward to products using our HNT,” said Wemett.
“Our goal is to use NaturalNano technology to commercialize products that will directly financially benefit our company.”